Nalgene Outdoor Increases Its Commitment to Manufacturing with Recycled Materials; New Products Kickoff Year-Long Goal to Convert All Bottle Production to Tritan Renew

Nalgene Outdoor Increases Its Commitment to Manufacturing with Recycled Materials; New Products Kickoff Year-Long Goal to Convert All Bottle Production to Tritan Renew Expanded styles and sizes of Nalgene Sustain line made from 50% recycled material offers a more sustainable way to reduce, reuse and recycle in one bottle ROCHESTER, N.Y., March 2, 2021 /PRNewswire/... Read more

Thermo Fisher Scientific Completes Acquisition of Mesa Biotech

WALTHAM, Mass., Feb. 26, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company. “Mesa Biotech is an important part of our strategy to expand the benefits of molecular diagnostics at... Read more

New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics

Measured more than a million collision cross sections (CCS) from whole-proteome digests of five organisms with trapped ion mobility spectrometry (TIMS) and parallel accumulation-serial fragmentation (PASEF) on several timsTOF Pro systems Large-scale CCS data from 360 LC-TIMS-MS/MS runs, processed with MaxQuant With CCS alignment, across 347,885 peptide CCS values measured in duplicate, the median coefficient... Read more

PerkinElmer Provides an Update on Valencia Branch Laboratory’s Accreditation Process

WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 22, 2021– PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory’s (VBL) accreditation process. The VBL is operated by PerkinElmer in partnership with the California Department of Public Health (CDPH). The VBL started operations on November 1,... Read more

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs WALTHAM, Mass., Feb. 17, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently... Read more

PerkinElmer Launches First Cell Painting Kit

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the first cell painting kit as part of its new portfolio of PhenoVue™ cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside the Company’s microplates, automation, software and industry-leading... Read more

Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results

Q4 2020 revenues up 4.6% year-over-year; organic revenue declines 0.4% Q4 2020 GAAP EPS of $0.45; non-GAAP EPS of $0.58 Expanded Project Accelerate 2.0 in proteomics, spatial biology and molecular diagnostics Strong revenue growth, Non-GAAP margin expansion and EPS growth expected in FY 2021 BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced financial results... Read more

Pacific Biosciences of California, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results

MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2020. Reported revenue is consistent with the Company’s press release issued on January 11, 2021. Q4 2020 Financial Highlights Revenue for the fourth quarter of 2020 was... Read more

Pacific Biosciences of California, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results

MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2020. Reported revenue is consistent with the Company’s press release issued on January 11, 2021. Q4 2020 Financial Highlights Revenue for the fourth quarter of 2020 was... Read more

Consolidated Financial Statements for the Third Quarter Ended December 31, 2020 FY2021 (April 1, 2020 – March 31, 2021)[UNAUDITED]

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more